Article/items published online ahead of print or online only
Latest Entry: Overall Survival Benefit in Resected NSCLC
9/22/2022 Overall Survival Benefit in Resected Non-Small Cell Lung Cancer
FDA ACTIONS & UPDATES
The latest approvals, designations, and new indications from the U.S. Food and Drug Administration for oncology drugs.
Latest: Tremelimumab +Durvalumab for Unresectable Hepatocellular Carcinoma
MUSINGS OF A CANCER DOCTORBy George W. Sledge, Jr., MDObservations, ponderings, and views.
Latest Entry: Breast Cancer at ASCO 2022: Some Big (and Smaller) Steps Forward
ONCOLOGISTS' GUIDE TO GENOMICSThe latest trends in genomics and molecular diagnostics for oncology.
Latest Entry: The Genomic Landscape of Pediatric Acute Lymphoblastic Leukemia
VIEW FROM THE OTHER SIDE OF THE STETHOSCOPEBy Wendy S. Harpham, MD, FACPA unique perspective on oncology practices.
Latest Entry: Surviving Loss & Grief
3 QUESTIONS ON...Answers straight from the experts on the latest news and topics in oncology.
Latest Entry: Optimizing the Strategy for Pancreatic Cancer Surveillance
August 25, 2016 - Volume 38 - FOCUS: Renal Cell Carcinoma Treatment & Research Updates 16
August 25, 2016
July 10, 2016 - Volume 38 - FOCUS: Renal Cell Carcinoma Treatment & Research Updates 13
February 10, 2013 - Volume 35 - SABCS Meeting Reporter Special Edition Supplement
All the latest news,
plus a look back at
OT's comprehensive coverage on...
And for more topics in oncology, browse our full list of
Exclusive interviews and perspectives from our iPad archives
Most Recently Added: "How Health IT is Changing Oncology"—Andrew Zelenetz, MD, PhD, Chief of the Lymphoma Service and Vice Chair of Medical Informatics at Memorial Sloan Kettering Cancer Center, tells OT how oncologists there are training a computer to understand and compare big data sets...